Literature DB >> 31189515

Differences in structure and function between human and murine tau.

Félix Hernández1, Raquel Cuadros1, Ivanna Ollá1, Carlos García2, Isidre Ferrer3, George Perry4, Jesús Avila5.   

Abstract

The main difference between the primary structures of human and mouse tau can be found at the N-terminal end of the protein. Residues 17 to 28 in human tau are not present in the mouse form of the molecule. Here we tested the capacity of these human tau residues to bind to specific proteins. Several proteins were observed to bind to these residues. Among those that showed the greatest binding were three related to energetic processes: enolase, glyceraldehyde 3 phosphate dehydrogenase and creatine kinase B. The latter did not bind to tau from brain extracts taken from patients with Alzheimer's disease (AD). This lack of binding could be due to the modification of CKB by oxidation in AD.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alzheimer disease; Creatine kinase; Tau

Mesh:

Substances:

Year:  2018        PMID: 31189515     DOI: 10.1016/j.bbadis.2018.08.010

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  6 in total

1.  Specific Peptide from the Novel W-Tau Isoform Inhibits Tau and Amyloid β Peptide Aggregation In Vitro.

Authors:  Raquel Cuadros; Mar Pérez; Daniel Ruiz-Gabarre; Félix Hernández; Vega García-Escudero; Jesús Avila
Journal:  ACS Chem Neurosci       Date:  2022-06-13       Impact factor: 5.780

Review 2.  Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders.

Authors:  Aurélie de Rus Jacquet; Hélèna L Denis; Francesca Cicchetti; Melanie Alpaugh
Journal:  Mol Psychiatry       Date:  2021-01-25       Impact factor: 13.437

3.  Mutant Presenilin 1 Dysregulates Exosomal Proteome Cargo Produced by Human-Induced Pluripotent Stem Cell Neurons.

Authors:  Sonia Podvin; Alexander Jones; Qing Liu; Brent Aulston; Charles Mosier; Janneca Ames; Charisse Winston; Christopher B Lietz; Zhenze Jiang; Anthony J O'Donoghue; Tsuneya Ikezu; Robert A Rissman; Shauna H Yuan; Vivian Hook
Journal:  ACS Omega       Date:  2021-05-13

4.  Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation.

Authors:  Matthew R Barron; Jane Gartlon; Lee A Dawson; Peter J Atkinson; Marie-Christine Pardon
Journal:  Front Immunol       Date:  2020-03-05       Impact factor: 7.561

5.  Behavioral Abnormalities in Knockout and Humanized Tau Mice.

Authors:  Rafaella Araujo Gonçalves; Nadeeja Wijesekara; Paul E Fraser; Fernanda G De Felice
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-12       Impact factor: 5.555

Review 6.  Differences Between Human and Murine Tau at the N-terminal End.

Authors:  Félix Hernández; Jesús Merchán-Rubira; Laura Vallés-Saiz; Alberto Rodríguez-Matellán; Jesús Avila
Journal:  Front Aging Neurosci       Date:  2020-01-28       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.